Clinical trial
Withdrawal of Heart Failure Treatment in Patients With Non-ischemic Cardiomyopathy, Without Late Gadolinium Enhancement and With a Negative Genetic Test, Who Have Been Super-responders to Cardiac Resynchronization Therapy.
NCT07851779 is registered in ClinicalTrials.gov with Institut d'Investigació Biomèdica de Bellvitge as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Withdrawal of Heart Failure Treatment in Patients With Non-ischemic Cardiomyopathy, Without Late Gadolinium Enhancement and With a Negative Genetic Test, Who Have Been Super-responders to Cardiac Resynchronization Therapy.
- Lead sponsor
- Institut d'Investigació Biomèdica de Bellvitge
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- January 14, 2026
- Completion date
- July 31, 2027
- Enrollment
- 64 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
cardiac resynchronisation therapy (crt), non-ischemic cardiomyopathy